Literature DB >> 16253608

Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol).

Mohammed N Khan1, Claire E Pothier, Michael S Lauer.   

Abstract

Chronotropic incompetence, or an inability to increase heart rate during exercise, independently predicts death in patients not taking beta blockers. Whether it predicts death in patients taking beta blockers is not known. Consecutive patients (n = 3,736; mean age 58 +/- 11 years; 68% men), who were taking either metoprolol tartrate or atenolol and were referred for symptom-limited exercise testing from 1990 to 2002 at a major academic medical center, formed the prospective study cohort. None had heart failure, pacemakers, atrial fibrillation, or any electrocardiographic abnormalities. Patients were followed for a median of 4.5 years for all-cause mortality. Chronotropic response was defined as the percentage of heart rate reserve used. A value of < or =62%, which was noted in 813 patients (22%), was considered abnormal, meaning that chronotropic incompetence was present. There were 173 deaths. After adjusting for age, gender, heart rate at rest, standard risk factors, other medications, Duke treadmill score, and heart rate recovery, chronotropic incompetence predicted death (adjusted hazard ratio 1.94, 95% confidence interval 1.43 to 2.64, p <0.0001). The association of chronotropic incompetence with death was present, irrespective of which drug was taken or the number of half-lives that had elapsed since the last dose. In conclusion, in patients taking beta blockers, chronotropic incompetence is independently predictive of death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253608     DOI: 10.1016/j.amjcard.2005.06.082

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  36 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Chronotropic incompetence as a risk predictor in children and young adults with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Sonia Franciosi; Thomas M Roston; Frances K G Perry; Bjorn C Knollmann; Prince J Kannankeril; Shubhayan Sanatani
Journal:  J Cardiovasc Electrophysiol       Date:  2019-07-11

Review 4.  Prevalence and management of chronotropic incompetence in heart failure.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

5.  Gender differences in the prognostic value of exercise treadmill test characteristics.

Authors:  Stacie L Daugherty; David J Magid; Jennifer R Kikla; John E Hokanson; Judith Baxter; Colleen A Ross; Frederick A Masoudi
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

6.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Authors:  Bishnu P Dhakal; Rajeev Malhotra; Ryan M Murphy; Paul P Pappagianopoulos; Aaron L Baggish; Rory B Weiner; Nicholas E Houstis; Aaron S Eisman; Stacyann S Hough; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2014-10-24       Impact factor: 8.790

7.  Exercise heart rates in patients with hypertrophic cardiomyopathy.

Authors:  Hong-Chang Luo; Veronica L Dimaano; Jackelyn M Kembro; Alex Hilser; David Hurtado-de-Mendoza; Iraklis Pozios; Miguel S Tomas; Hulya Yalcin; Ketty Dolores-Cerna; Wilfredo Mormontoy; Miguel A Aon; Duke Cameron; David A Bluemke; Kerry J Stewart; Stuart D Russell; Jorge G Cordova; Theodore P Abraham; M Roselle Abraham
Journal:  Am J Cardiol       Date:  2015-02-04       Impact factor: 2.778

Review 8.  Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.

Authors:  David Feldman; Terry S Elton; Doron M Menachemi; Randy K Wexler
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

9.  Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.

Authors:  Daniela Dobre; Faiez Zannad; Steven J Keteyian; Susanna R Stevens; Patrick Rossignol; Dalane W Kitzman; Joel Landzberg; Jonathan Howlett; William E Kraus; Stephen J Ellis
Journal:  Eur Heart J       Date:  2013-01-12       Impact factor: 29.983

10.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.